跳至主要内容
临床试验/NCT07436962
NCT07436962招募中不适用

Loop Recorder Implantation in Patients With Mitral Annular Disjunction

Gottsegen National Cardiovascular Institute1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年12月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20
试验地点
1
主要终点
Ventricular arrhythmia screened with loop recorder

研究概览

简要总结

The goal of clinical trial is to prospectively collect data to investigate the prevalence of arrhythmia in young patients diagnosed with mitral annular disjunction who have no indication for implantable cardioverter defibrillator (ICD) or implantable loop recorder (ILR) implantation according to the current guideline. The study population is young (age 18-60), the participating patients have mitral annular disjunction confirmed by echocardiography and MR scan confirmed late-type gadolinium enhancement in the myocardium. This patient population has an increased risk of ventricular arrhythmias and sudden cardiac death. The investigators plan to implant 20 BioMonitor IIIm ILRs over a year in patients with mild or uncertain symptoms (dizziness, palpitations) and no malignant arrhythmias.

Aims of the study:

  1. Screening of asymptomatic patients with MAD for arrhythmia.
  2. In case of symptoms, to prove or exclude the underlying arrhythmia.

BioMonitor IIIm ILR implantation is planned in the following patient population:

  1. Inclusion of 20 patients with mitral annular disjunction confirmed by echocardiography and late gadolinium enhancement in the myocardium by MRI.
  2. Only patients who do not meet the current indication for ICD or ILR implantation based on the current recommendation will be included in the study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •age between 18 and 60 years
  • •patient not incapacitated
  • •mitral annular disjunction confirmed by echocardiography
  • •MR scan confirmed late-type gadolinium enhancement in the myocardium

排除标准

  • •lack of informed consent
  • •age under 18 years
  • •limited capability
  • •guardianship
  • •active infection
  • •previous ICD implantation
  • •indication for ICD or ILR implantation based on current recommendation

研究组 & 干预措施

MAD-ILR

Experimental

Patients with mitral annular disjunction, confirmed by echocardiography and MR scan confirmed late-type gadolinium enhancement in the myocardium, undergoing loop recorder implantation.

干预措施: loop recorder implantation (Device)

结局指标

主要结局

Ventricular arrhythmia screened with loop recorder

时间窗: 24 months

Periprocedurally, at 6-, 12-, 18- and 24-month follow-up, we perform control examinations (e.g. 12-lead ECG, echocardiography, ILR interrogation). Arrhythmias recorded by ILR are documented and analyzed. Our results may contribute to a better understanding of the indications for ILR and ICD implantation in patients with MAD, thereby helping to reduce the risk of sudden cardiac death.

次要结局

未报告次要终点

研究者

发起方
Gottsegen National Cardiovascular Institute
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验